Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00865787 · ClinicalTrials.gov registry record
Effects of EGCG-Enhanced Extra Virgin Olive Oil on Endothelial Function
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 83
- Enrollment target
NCT00865787: Completed study, sponsored by Mayo Clinic.
NCT00865787 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 83 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00865787 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
Study Summary
This study is being done to determine if the use of EGCG-Enhanced Extra Virgin Olive Oil in a daily diet will improve endothelial function.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-04 |
What the finished NCT00865787 record still lists
NCT00865787 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 83 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00865787 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00865787 about?
NCT00865787 is a clinical study titled "Effects of EGCG-Enhanced Extra Virgin Olive Oil on Endothelial Function". This study is being done to determine if the use of EGCG-Enhanced Extra Virgin Olive Oil in a daily diet will improve endothelial function.
What is the current status of trial NCT00865787?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2008-02. Estimated completion is 2010-04.
Who is sponsoring clinical trial NCT00865787?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia